Orchid Pharma Ltd - 524372 - Global Depository Receipts (GDR) - Termination Of Rule 144A And Regulation S Deposit Agreements And Delisting Of GDR'S From The Luxembourg Stock Exchange
Global Depository Receipts (GDR) - Termination of Rule 144A and Regulation S Deposit Agreements and Delisting of GDR's from the Luxembourg Stock Exchange Orchid Pharma Ltd - 524372 - Global Depository Receipts- Notice Of Cancellation Of Admission To Trading On The London Stock Exchange-Reg.
Global Depository Receipts- Notice of cancellation of admission to trading on the London Stock Exchange-Reg. Orchid Pharma Ltd - 524372 - Global Depository Receipts- Notice Of Cancellation Of Admission To Trading On The London Stock Exchange-Reg.
Global Depository Receipts- Notice of cancellation of admission to trading on the London Stock Exchange-Reg. Orchid Pharma Ltd - 524372 - Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30,2021
Unaudited financial results (Standalone and Consolidated) for the quarter and half year ended September 30,2021 Orchid Pharma Ltd - 524372 - Board Meeting Outcome for Outcome Of Board Meeting - Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2021
Outcome of Board Meeting - Approval of Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 2021 Orchid Pharma Ltd - 524372 - Newspaper Advertisement On Intimation Of Dispatch Of Postal Ballot Notice
Newspaper Advertisement on intimation of dispatch of Postal Ballot Notice Orchid Pharma Ltd - 524372 - Disclosure Under Regulation 30 Of The SEBI(LODR) Regulations,2015- Notice Of Postal Ballot
Disclosure under Regulation 30 of the SEBI(LODR) Regulations,2015- Notice of Postal Ballot Orchid Pharma Ltd - 524372 - Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results (Standalone And Consolidated} For The Quarter And Half Year Ended September 30, 2021.
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2021 ,inter alia, to consider and approve To consider and approve the Unaudited financial results (Standalone and Consolidated} for the quarter and half year ended September 30, 2021. Orchid Pharma Ltd - 524372 - Outcome Of Board Meeting Held On November 01, 2021
Outcome of Board meeting held on November 01, 2021 Orchid Pharma Ltd - 524372 - Shareholding for the Period Ended September 30, 2021
Orchid Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here